1,408
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation

, ORCID Icon, ORCID Icon, , , , , , , , , , & show all
Pages 2773-2783 | Received 16 Jul 2022, Accepted 15 Aug 2022, Published online: 28 Aug 2022

References

  • Abd-Elrasheed E, Nageeb El-Helaly S, El-Ashmoony MM, et al. (2018). Brain-targeted intranasal zaleplon solid dispersion in hydrophilic carrier system; 23 full-factorial design and in vivo determination of GABA neurotransmitter. Drug Dev Ind Pharm 44: 741–9.
  • Al-Amodi Yasir A, Hosny KM, Alharbi WS, et al. (2020). Investigating the potential of transmucosal delivery of febuxostat from oral lyophilized tablets loaded with a self-nanoemulsifying delivery system. Pharmaceutics 12:534.
  • Alhakamy NA, Hosny KM. (2019). Nano-vesicular delivery system loaded by bifonazole: preparation, optimization, and assessment of pharmacokinetic and antifungal activity. J Drug Delivery Sci Technol 49:316–22.
  • Alhakamy NA, Hosny KM, Aldryhim AY, et al. (2022). Development and optimization of ofloxacin as solid lipid nanoparticles for enhancement of its ocular activity. J Drug Delivery Sci Technol 72:103373.
  • Bakhaidar RB, Hosny KM, Mahier IM, et al. (2022). Development and optimization of a tamsulosin nanostructured lipid carrier loaded with saw palmetto oil and pumpkin seed oil for treatment of benign prostatic hyperplasia. Drug Deliv 29:2579–91.
  • Bhatt P, Madhav S. (2011). A detailed review on nanoemulsion drug delivery system. Int J Pharm Sci Res 2: 2292–8.
  • Buysse DJ, Angst J, Gamma A, et al. (2008). Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31: 473–80.
  • Chen YD, Liang ZY, Cen YY, et al. (2015). Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma. Drug Des Devel Ther 9:5815–25.
  • Chinna Reddy P, Chaitanya KS, Madhusudan Rao Y. (2011). A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. Daru 19:385–403.
  • Chinwala M. (2020). Recent formulation advances and therapeutic usefulness of orally disintegrating tablets (ODTs). Pharmacy (Basel) 108:186.
  • Cui J, Yu B, Zhao Y, et al. (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 371:148–55.
  • De Jong WH, Borm PJ. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3: 133–49.
  • Dudhipala N. (2016). A review of novel formulation strategies to enhance oral delivery of zaleplon. J Bioequiv Availab 8:211–3.
  • Ebbens MM, Verster JC. (2010). Clinical evaluation of zaleplon in the treatment of insomnia. Nat Sci Sleep 2: 115–26.
  • El-Say KM, Ahmed TA, Ahmed OAA, et al. (2017). Self-nanoemulsifying lyophilized tablets for flash oral transmucosal delivery of vitamin K: development and clinical evaluation. J Pharm Sci 106:2447–56.
  • Foda NH, Bakhaidar RB. (2010). Zaleplon. In: Brittain H. (ed.), Profiles of drug substances, excipients and related methodology, Vol. 35. Milford, NY: Center of pharmaceutical physics,Academic Press, 347–71.
  • Ghourichay MP, Kiaie SH, Nokhodchi A, Javadzadeh Y. (2021). Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives. Biomed Res Int 2021:6618934.
  • Hosny K, Asfour H, Rizg W, et al. (2021). Formulation, optimization, and evaluation of oregano oil nanoemulsions for the treatment of infections due to oral microbiota. Int J Nanomedicine 16:5465–78.
  • Hosny KM, Banjar ZM. (2013). The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin Drug Deliv 10:1033–41.
  • Hosny KM, El-Say KM, Ahmed OA. (2016). Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment. Drug Deliv 23:355–61.
  • Hosny KM, Rizg WY. (2018). Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis. PloS One 13:e0197540.
  • Hosny KM, Rizg WY, Khallaf RA. (2020). Preparation and optimization of in situ gel loaded with rosuvastatin-ellagic acid nanotransfersomes to enhance the anti-proliferative activity. Pharmaceutics 12:263.
  • Hua S. (2019). Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front Pharmacol 10:1328.
  • Hosny K, Khames A, Elhady S. (2006). ‘Preparation and evaluation of simvastatin orodispersible tablets containing soy polysaccharide and potassium polacrillin as novel superdisintegrants. Int J Pharm Sci Res 4: 96–9.
  • Khalifa MKA, Salem HA, Shawky SM, et al. (2019). Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients. Drug Deliv 26:1243–53.
  • Indiran Pather S, Rathbone MJ, Senel S. (2008). Current status and the future of buccal drug delivery systems. Expert Opin Drug Deliv 5:531–42.
  • Lovelyn C, Attama AA. (2011). Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol 2: 626–39.
  • Manda P, Popescu C, Juluri A, et al. (2018). Micronized zaleplon delivery via orodispersible film and orodispersible tablets. AAPS PharmSciTech. 19: 1358–66.
  • Md S, Mujtaba MA, Lim WM, et al. (2021). Nanoemulsions to preserve/process bioactive and nutritional food compounds: contemporary research and applications. In: Ahmad J, Nollet LM. (eds.), Nanoemulsions in food technology, London: Taylor & Francis eBooks, 247–78.
  • Morin CM, Drake CL, Harvey AG, et al. (2015). Insomnia disorder. Nat Rev Dis Primers 1: 1437–44.
  • Naahidi S, Jafari M, Edalat F, et al. (2013). Biocompatibility of engineered nanoparticles for drug delivery. J Control Release 166: 182–94.
  • Nafady MM. (2014). Pharmaceutical studies on flash tablets of a highly soluble metformin hydrochloride. Int J Pharm Pharm Sci 6: 561–7.
  • Nielsen HM, Rassing MR. (1999). TR146 cells grown on filters as a model of human buccal epithelium. Permeability enhancement by different pH value, different osmolarity value and bile salts. Int. J. Pharm 185:215–25.
  • Ochekpe NA, Olorunfemi PO, Ngwuluka NC. (2009). Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Trop J Pharm Res 8: 275–87.
  • Pabari RM, Ramtoola Z. (2012). Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets. Int J Pharm 430: 18–25.
  • Park K. (2013). Facing the truth about nanotechnology in drug delivery. ACS Nano 7:7442–7.
  • Popescu C. (2015). Enhanced dissolution efficiency of zaleplon solid dispersions via modified β-cyclodextrin molecular inclusion complexes. J Pharm Pharm Sci 1: 12–21.
  • Qaseem A, Kansagara D, Forciea MA, Clinical Guidelines Committee of the American College of Physicians, et al. (2016). Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians. Ann Intern Med 165:125–33.
  • Rao TN, Srineevasula REG, Patrudu TB, Parvathamma T. (2012). Estimation of zaleplon by a new RP-HPLC method. J Chem Pharm Research 4:3010–4.
  • Rizg WY, Hosny KM, Elgebaly SS, et al. (2021). Preparation and optimization of garlic oil/apple cider vinegar nanoemulsion loaded with minoxidil to treat alopecia. Pharmaceutics 13:2150.
  • Rizg WY, Hosny KM, Mahmoud SS, et al. (2022). Repurposing lovastatin cytotoxicity against the tongue carcinoma HSC3 cell line using a eucalyptus oil-based nanoemulgel carrier. Gels 8:176.
  • Sakhare SS. (2017). Chitosan-based zaleplon nasal microparticles. Asian J Pharm 11: 279–89.
  • Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. (2007). Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 8: E12–7.
  • Shah P, Bhalodia D, Shelat P. (2010). Nanoemulsion: a pharmaceutical review. Syst Rev Pharm 1: 24–32.
  • Sharma D. (2013). Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders. ISRN Pharmaceutics 2013: 1–8.
  • Shojaei AH, Chang RK, Guo X. (2001). Systemic drug delivery via the buccal mucosal route. J Pharm Technol 25:70–81.
  • Singh Y, Meher JG, Raval K, et al. (2017). Nanoemulsion: concepts, development and applications in drug delivery. J Control Release 252: 28–49.
  • Tiwari SB, Shenoy DB, Amiji MM. (2006). Nanoemulsion formulations for improved oral delivery of poorly soluble drugs. NSTI-Nanotech 1: 475–8.
  • Vermeeren A, et al. (2017). Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25: 224–31.
  • Zidan AS, Aljaeid BM, Mokhtar M, et al. (2015). Taste-masked orodispersible tablets of cyclosporine self-nanoemulsion lyophilized with dry silica. Pharm Dev Technol 20: 652–61.
  • Zülli F, Belser E, Schmid D, et al. (2006). Preparation and properties of coenzyme Q10 nanoemulsions. Cosmetic Sci Technol 40–6.